Shanghai Kaibao Pharmaceutical (300039) — Net Asset Momentum
Shanghai Kaibao Pharmaceutical (300039) recorded a net asset momentum of 7.7% as of December 2025, with net assets of CN¥4.42 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is Shanghai Kaibao Pharmaceutical's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Shanghai Kaibao Pharmaceutical Net Asset Momentum (2006–2025)
This chart tracks Shanghai Kaibao Pharmaceutical's year-over-year net asset growth across 20 annual reporting periods from 2006 to 2025. The most recent momentum reading is +7.7%, with net assets of CN¥4.42 Billion CNY as of December 2025. For live market cap and overall valuation, see Shanghai Kaibao Pharmaceutical market cap and net worth.
Annual Net Asset History for Shanghai Kaibao Pharmaceutical (2006–2025)
The table below shows the complete annual net asset history for Shanghai Kaibao Pharmaceutical from 2006 to 2025, covering 20 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check 300039 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥4.42 Billion | CN¥4.78 Billion | CN¥359.64 Million | ▲ +7.7% |
| 2024 | CN¥4.10 Billion | CN¥4.52 Billion | CN¥415.45 Million | ▲ +1.7% |
| 2023 | CN¥4.03 Billion | CN¥4.58 Billion | CN¥546.82 Million | ▲ +7.2% |
| 2022 | CN¥3.76 Billion | CN¥4.26 Billion | CN¥498.24 Million | ▲ +23.5% |
| 2021 | CN¥3.04 Billion | CN¥3.36 Billion | CN¥310.90 Million | ▲ +18.1% |
| 2020 | CN¥2.58 Billion | CN¥2.88 Billion | CN¥298.96 Million | ▲ +0.3% |
| 2019 | CN¥2.57 Billion | CN¥2.84 Billion | CN¥273.01 Million | ▲ +3.4% |
| 2018 | CN¥2.49 Billion | CN¥2.75 Billion | CN¥262.26 Million | ▲ +5.1% |
| 2017 | CN¥2.37 Billion | CN¥2.68 Billion | CN¥314.26 Million | ▲ +7.5% |
| 2016 | CN¥2.20 Billion | CN¥2.53 Billion | CN¥327.61 Million | ▲ +9.7% |
| 2015 | CN¥2.01 Billion | CN¥2.43 Billion | CN¥421.16 Million | ▲ +6.4% |
| 2014 | CN¥1.88 Billion | CN¥2.12 Billion | CN¥232.72 Million | ▲ +17.3% |
| 2013 | CN¥1.61 Billion | CN¥1.77 Billion | CN¥164.72 Million | ▲ +13.2% |
| 2012 | CN¥1.42 Billion | CN¥1.56 Billion | CN¥142.29 Million | ▲ +6.3% |
| 2011 | CN¥1.33 Billion | CN¥1.45 Billion | CN¥117.97 Million | ▲ +7.9% |
| 2010 | CN¥1.24 Billion | CN¥1.37 Billion | CN¥133.39 Million | ▲ +7.9% |
| 2009 | CN¥1.15 Billion | CN¥1.35 Billion | CN¥199.20 Million | ▲ +803.0% |
| 2008 | CN¥126.92 Million | CN¥229.88 Million | CN¥102.95 Million | ▲ +64.9% |
| 2007 | CN¥76.96 Million | CN¥161.61 Million | CN¥84.64 Million | ▲ +106.7% |
| 2006 | CN¥37.24 Million | CN¥109.03 Million | CN¥71.80 Million | — |